About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2012 (2012), Article ID 181964, 11 pages
http://dx.doi.org/10.1155/2012/181964
Review Article

Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis

1Department of Urology, National Cheng Kung University Hospital, Tainan 70403, Taiwan
2Department of Urology, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan
3Department of Pathology, College of Medicine, National Cheng Kung University Hospital, Tainan 70403, Taiwan

Received 4 April 2012; Revised 16 May 2012; Accepted 16 May 2012

Academic Editor: Trinity J. Bivalacqua

Copyright © 2012 Yuh-Shyan Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Petros D. Grivas, Kathleen C. Day, Andreas Karatsinides, Alyssa Paul, Nazia Shakir, Iya Owainati, Monica Liebert, Lakshmi P. Kunju, Dafydd Thomas, and Maha Hussain, “Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Blad der Cancer,” Molecular Medicine, vol. 19, pp. 377–386, 2013. View at Publisher · View at Google Scholar
  • Kai Wang, Laurie M. Gay, Rami N. Al-Rohil, Tipu Nazeer, Christine E. Sheehan, Timothy A. Jennings, Geoff A. Otto, Amy Donahue, Jie He, Gary Palmer, Siraj Ali, Michelle Nahas, Geneva Young, Elaine LaBrecque, Garrett Frampton, Rachel Erlich, John A. Curran, Kristina Brennan, Sean R. Downing, Roman Yelensky, Doron Lipson, Matthew Hawryluk, Vincent A. Miller, and Philip J. Stephens, “A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation i n Micropapillary Urothelial Carcinoma,” Clinical Cancer Research, vol. 20, no. 1, pp. 68–75, 2014. View at Publisher · View at Google Scholar